![PDF) Combining Biologically Active β-Lactams Integrin Agonists with Poly(L-lactic acid) Nanofibers: Enhancement of Human Mesenchymal Stem Cell Adhesion PDF) Combining Biologically Active β-Lactams Integrin Agonists with Poly(L-lactic acid) Nanofibers: Enhancement of Human Mesenchymal Stem Cell Adhesion](https://i1.rgstatic.net/publication/339014113_Combining_Biologically_Active_b-Lactams_Integrin_Agonists_with_PolyL-lactic_acid_Nanofibers_Enhancement_of_Human_Mesenchymal_Stem_Cell_Adhesion/links/6064a4ada6fdcc83855ab40e/largepreview.png)
PDF) Combining Biologically Active β-Lactams Integrin Agonists with Poly(L-lactic acid) Nanofibers: Enhancement of Human Mesenchymal Stem Cell Adhesion
![PDF) Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism | Paolo Ferrari - Academia.edu PDF) Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism | Paolo Ferrari - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/44415323/mini_magick20190214-19524-k9e2t5.png?1550185328)
PDF) Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism | Paolo Ferrari - Academia.edu
![Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy - Cytotherapy Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy - Cytotherapy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/faa971f1-98e0-441c-9db9-0ab8b0748aff/gr1.jpg)
Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy - Cytotherapy
![Cellular nanovesicles for therapeutic immunomodulation: a perspective on engineering strategies and new advances - ScienceDirect Cellular nanovesicles for therapeutic immunomodulation: a perspective on engineering strategies and new advances - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211383522003719-gr1.jpg)
Cellular nanovesicles for therapeutic immunomodulation: a perspective on engineering strategies and new advances - ScienceDirect
![Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy - Cytotherapy Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy - Cytotherapy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/736d6cfa-488b-4ff2-a839-77903ab7b249/gr7_lrg.jpg)
Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy - Cytotherapy
![Cancers | Free Full-Text | Immune Regulation by Dendritic Cell Extracellular Vesicles in Cancer Immunotherapy and Vaccines | HTML Cancers | Free Full-Text | Immune Regulation by Dendritic Cell Extracellular Vesicles in Cancer Immunotherapy and Vaccines | HTML](https://www.mdpi.com/cancers/cancers-12-03558/article_deploy/html/images/cancers-12-03558-ag.png)